These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Effect of HSP90 function inhibited on the telomerase and P53 mutant in breast cancer cells].
    Author: Li X, Deng HY.
    Journal: Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 39(2):181-3. PubMed ID: 18630678.
    Abstract:
    OBJECTIVE: To investigate the effect of heat shock protein 90 (Hsp90) function inhibited on the telomerase activity and P53 expression in human breast cancer cells, in which a specific inhibitor geldanamycin (GA) was used to inhibit Hsp90 function. METHODS: Human breast cancer cell line MDA-MB-435s was used for the study. Proliferation of MDA-MB-435s cells was measured with MTT assay. Cell cycle was analyzed by flow cytometry. The telomerase activity was measured by TRAP-ELISA assay. The protein expression of mutant P53 in cells was detected by Western blot. RESULTS: GA inhibited the proliferation of MDA-MB-435s cells on a time- and dose-depending manner. After treated with GA, MDA-MB-435s cells arrested at G2/M phase. The telomerase activity of cells was decreasing, the expression level of mutant P53 protein in MDA-MB-435s cells was reduced obviously compared with that in control cells. CONCLUSION: The telomerase activation and mutant P53 expression in MDA-MB-435s cells are related to HSP90 function, of which the inhibition with GA can decrease the telomerase activity and the protein expression of mutant P53, and further repress the proliferation of MDA-MB-435s cells.
    [Abstract] [Full Text] [Related] [New Search]